AI has the potential to change practice patterns, improve imaging, and inform treatment planning for patients with brain tumors.
Nicholas Blondin, MD
Advertisement
Articles by Nicholas Blondin, MD
Oncology clinicians can effectively collaborate with neuroradiologists using advanced techniques to improve brain tumor characterization.
Nicholas Blondin, MD, discusses the latest advancements in immunotherapy for brain cancer as well as emerging strategies, including CAR T-cell therapy.
Advertisement
Latest Updated Articles
Optimizing Brain Tumor Management With Advanced NeuroimagingPublished: May 13th 2025 | Updated:
- The Evolving Role of Immunotherapy in Primary and Metastatic Brain Cancer
Published: May 12th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases
3
Which Therapy Has the Best Efficacy in Transplant-Ineligible NDMM?
4
Companion Diagnostic Earns FDA Approval for Imlunestrant in Breast Cancer
5
